Inhaltsbereich
| 92 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
 Druckansicht
|
| Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy. |
| Höbaus J, Tennakoon S, Heffeter P, Groeschel C, Aggarwal A, Hummel DM, Thiem U, Marculescu R, Berger W, Kállay E |
| International journal of cancer. Journal international du cancer. 2015 Aug 3. doi: 10.1002/ijc.29717 |
| PMID: 26238339 |
| Fibroblast growth factor receptor 3 isoforms: novel therapeutic targets for hepatocellular carcinoma? |
| Paur J, Nika L, Maier C, Moscu-Gregor A, Kostka J, Huber D, Mohr T, Heffeter P, Schrottmaier WC, Kappel S, Kandioler D, Holzmann K, Marian B, Berger W, Grusch M, Grasl-Kraupp B |
| Hepatology (Baltimore, Md.). 2015 Aug 1. doi: 10.1002/hep.28023 |
| PMID: 26235436 |
| EVI1 promotes tumor growth via transcriptional repression of MS4A3. |
| Heller G, Rommer A, Steinleitner K, Etzler J, Hackl H, Heffeter P, Tomasich E, Filipits M, Steinmetz B, Topakian T, Klingenbrunner S, Ziegler B, Spittler A, Zöchbauer-Müller S, Berger W, Wieser R |
| Journal of hematology & oncology. 2015 Mar 21. doi: 10.1186/s13045-015-0124-6. pii: 10.1186/s13045-015-0124-6. pmc: PMC4389965 |
| PMID: 25886616 |
| Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates. |
| Seršen S, Kljun J, Kryeziu K, Panchuk R, Alte B, Körner W, Heffeter P, Berger W, Turel I |
| Journal of medicinal chemistry. 2015 Apr 17. doi: 10.1021/acs.jmedchem.5b00288 |
| PMID: 25856666 |
| Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells. |
| Gröschel C, Aggarwal A, Tennakoon S, Höbaus J, Prinz-Wohlgenannt M, Marian B, Heffeter P, Berger W, Kállay E |
| The Journal of steroid biochemistry and molecular biology. 2015 Mar 14. pii: S0960-0760(15)00049-7. doi: 10.1016/j.jsbmb.2015.02.011 |
| PMID: 25777538 |
| Active vitamin D potentiates the anti-neoplastic effects of calcium in the colon: A cross talk through the calcium-sensing receptor. |
| Aggarwal A, Höbaus J, Tennakoon S, Prinz-Wohlgenannt M, Graça J, Price SA, Heffeter P, Berger W, Baumgartner-Parzer S, Kállay E |
| The Journal of steroid biochemistry and molecular biology. 2015 Mar 7. pii: S0960-0760(15)00044-8. doi: 10.1016/j.jsbmb.2015.02.006 |
| PMID: 25758239 |
| Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance. |
| Miklos W, Pelivan K, Kowol CR, Pirker C, Dornetshuber-Fleiss R, Spitzwieser M, Englinger B, van Schoonhoven S, Cichna-Markl M, Koellensperger G, Keppler BK, Berger W, Heffeter P |
| Cancer letters. 2015 Mar 5. pii: S0304-3835(15)00164-0. doi: 10.1016/j.canlet.2015.02.049 |
| PMID: 25749419 |
| The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo. |
| Dornetshuber-Fleiss R, Heilos D, Mohr T, Richter L, Süssmuth RD, Zlesak M, Novicky A, Heffeter P, Lemmens-Gruber R, Berger W |
| Biochemical pharmacology. 2014 Dec 31. pii: S0006-2952(14)00727-8. doi: 10.1016/j.bcp.2014.12.013. pmc: PMC4379350. mid: EMS62789 |
| PMID: 25557295 |
| Calpain-mediated integrin deregulation as a novel mode of action for the anticancer gallium compound KP46. |
| Jungwirth U, Gojo J, Tuder T, Walko G, Holcmann M, Schöfl T, Nowikovsky K, Wilfinger N, Schoonhoven S, Kowol CR, Lemmens-Gruber R, Heffeter P, Keppler BK, Berger W |
| Molecular cancer therapeutics. 2014 Jul 31. pii: 1535-7163.MCT-14-0087. doi: 10.1158/1535-7163.MCT-14-0087 |
| PMID: 25082959 |
| Water-Soluble, Biocompatible Polyphosphazenes with Controllable and pH-Promoted Degradation Behavior. |
| Wilfert S, Iturmendi A, Schoefberger W, Kryeziu K, Heffeter P, Berger W, Brüggemann O, Teasdale I |
| Journal of polymer science. Part A, Polymer chemistry. 2014 Apr 14. doi: 10.1002/pola.27002. pmc: PMC3980369. mid: EMS57739 |
| PMID: 24729657 |
| Triapine and a more potent dimethyl derivative induce endoplasmic reticulum stress in cancer cells. |
| Trondl R, Flocke LS, Kowol CR, Heffeter P, Jungwirth U, Mair GE, Steinborn R, Enyedy ÉA, Jakupec MA, Berger W, Keppler BK |
| Molecular pharmacology. 2013 Dec 30. pii: mol.113.090605. doi: 10.1124/mol.113.090605 |
| PMID: 24378333 |
| The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo. |
| Heffeter P, Atil B, Kryeziu K, Groza D, Koellensperger G, Körner W, Jungwirth U, Mohr T, Keppler BK, Berger W |
| European journal of cancer (Oxford, England : 1990). 2013 Jun 18. pii: S0959-8049(13)00426-7. doi: 10.1016/j.ejca.2013.05.018. pmc: PMC3807657 |
| PMID: 23790465 |
| Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair. |
| Kryeziu K, Jungwirth U, Hoda MA, Ferk F, Knasmüller S, Karnthaler-Benbakka C, Kowol CR, Berger W, Heffeter P |
| Molecular cancer therapeutics. 2013 Apr 2. pii: 1535-7163.MCT-13-0065. doi: 10.1158/1535-7163.MCT-13-0065 |
| PMID: 23548265 |
| EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells. |
| Rommer A, Steinmetz B, Herbst F, Hackl H, Heffeter P, Heilos D, Filipits M, Steinleitner K, Hemmati S, Herbacek I, Schwarzinger I, Hartl K, Rondou P, Glimm H, Karakaya K, Krämer A, Berger W, Wieser R |
| PloS one. 2013 Feb 14. doi: 10.1371/journal.pone.0056308. pii: PONE-D-12-22575. pmc: PMC3572987 |
| PMID: 23457546 |
| Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones. |
| Heffeter P, Pirker C, Kowol CR, Herrman G, Dornetshuber R, Miklos W, Jungwirth U, Koellensperger G, Keppler BK, Berger W |
| Biochemical pharmacology. 2012 Mar 15. pii: S0006-2952(12)00196-7. doi: 10.1016/j.bcp.2012.03.004. pmc: PMC3342514 |
| PMID: 22426010 |
| Anticancer activity of methyl-substituted oxaliplatin analogs. |
| Jungwirth U, Xanthos DN, Gojo J, Bytzek AK, Körner W, Heffeter P, Abramkin SA, Jakupec MA, Hartinger CG, Windberger U, Galanski M, Keppler BK, Berger W |
| Molecular pharmacology. 2012 Feb 13. pii: mol.111.077321. doi: 10.1124/mol.111.077321. pmc: PMC3375001. mid: UKMS48669 |
| PMID: 22331606 |
| Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition. |
| Metzner T, Bedeir A, Held G, Peter-Vörösmarty B, Ghassemi S, Heinzle C, Spiegl-Kreinecker S, Marian B, Holzmann K, Grasl-Kraupp B, Pirker C, Micksche M, Berger W, Heffeter P, Grusch M |
| The Journal of investigative dermatology. 2011 Jul 14. pii: jid2011177. doi: 10.1038/jid.2011.177. pmc: PMC3383623. mid: UKMS48843 |
| PMID: 21753785 |
| EGCG-meditated cyto- and genotoxicity in HaCat keratinocytes is impaired by cell-mediated clearance of auto-oxidation-derived H2O2: an algorithm for experimental setting correction. |
| Elbling L, Herbacek I, Weiss RM, Gerner C, Heffeter P, Jantschitsch C, Trautinger F, Grusch M, Pangratz H, Berger W |
| Toxicology letters. 2011 Jun 15. pii: S0378-4274(11)01265-3. doi: 10.1016/j.toxlet.2011.06.001 |
| PMID: 21704138 |
| Anticancer activity of metal complexes: involvement of redox processes. |
| Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W, Heffeter P |
| Antioxidants & redox signaling. 2011 May 11. doi: 10.1089/ars.2010.3663. pmc: PMC3371750. mid: UKMS48667 |
| PMID: 21275772 |
| Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339. |
| Heffeter P, Böck K, Atil B, Reza Hoda MA, Körner W, Bartel C, Jungwirth U, Keppler BK, Micksche M, Berger W, Koellensperger G |
| Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry. 2010 Mar 11. doi: 10.1007/s00775-010-0642-1. pmc: PMC3371400. mid: UKMS48674 |
| PMID: 20221888 |
| 92 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
